Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Curevac N.V.
(NQ:
CVAC
)
3.310
+0.120 (+3.76%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Curevac N.V.
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Bill And Melinda Gates' Divorce News A Bull Case For GameStop? What You Need To Know
May 04, 2021
A post by a member of the Reddit investor forum r/GME in March that speculated billionaires were increasing their short positions in GameSt...
Via
Benzinga
CureVac's Vaccine Might Protect Against the South African Variant
May 01, 2021
The promising data in mice needs to translate into humans.
Via
The Motley Fool
Exposures
COVID-19
Could These 3 Brilliant mRNA Stocks Make You Millions?
April 30, 2021
Probably not, but at least one of them could make you thousands over time.
Via
The Motley Fool
Exposures
COVID-19
Best Biotech Stocks & ETFs for mRNA, Gene Editing
April 29, 2021
2020 was the most challenging year in decades but it was great for scientific innovation, particularly in the biotech space.
Via
Talk Markets
CureVac's Potential Has Wall Street Sending Mixed Signals
April 26, 2021
The biotech still has a long way to go to prove itself and justify its current stock valuation.
Via
The Motley Fool
Exposures
COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For April 26, 2021
April 26, 2021
Upgrades Susquehanna upgraded the previous rating for Axalta Coating Systems Ltd (NYSE:AXTA) from Neutral to Positive. The current stock performance of Axalta Coating Sys...
Via
Benzinga
2 Reasons This COVID Vaccine Latecomer Could Gain Major Market Share
April 21, 2021
A big market is in big need of more vaccines.
Via
The Motley Fool
Exposures
COVID-19
7 Health Care Stocks Showing Unusual Options Activity In Today's Session
April 19, 2021
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...
Via
Benzinga
CureVac Swiss AG Initiates Rolling Submission Process for mRNA-based COVID-19 Vaccine Candidate, CVnCoV, with Swissmedic
April 19, 2021
- Rolling submission to accelerate time to marketing authorization of CVnCoV in Switzerland - Review process started with submission of first CVnCoV data package TÜBINGEN, GERMANY and BOSTON, MA /...
From
CureVac
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
CureVac (CVAC) Q4 2020 Earnings Call Transcript
April 15, 2021
CVAC earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Why PPD, Immunic, Inovio and CureVac Shares Are Higher Today
April 15, 2021
PPD, Inc. (NASDAQ: PPD), Immunic, Inc. (NASDAQ: IMUX), Inovio Pharmaceuticals, Inc. (NASDAQ: INO) and CureVac N.V. (NASDAQ: CVAC) are among the healthcare movers on Thursday. PPD...
Via
Benzinga
CureVac Announces Financial Results and Business Updates for the Fourth Quarter and Full-Year of 2020
April 15, 2021
- COVID-19 vaccine candidate: CVnCoV in final stage of clinical development and believed to be well on track to provide data for conditional approval based on EMA rolling submission - Pivotal Phase...
From
CureVac
Via
AccessWire
Topics
Initial Public Offering
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
22 Stocks Moving in Thursday's Pre-Market Session
April 15, 2021
Gainers Assertio Holdings, Inc. (NASDAQ: ASRT) rose 25.1% to $0.6485 in pre-market trading. Bit Digital, Inc. (NASDAQ: BTBT) rose 15.1% to $16.40 in pre-market trading after...
Via
Benzinga
Earnings Scheduled For April 15, 2021
April 15, 2021
Companies Reporting Before The Bell • Charles Schwab (NYSE:SCHW) is projected to report quarterly earnings at $0.82 per share on revenue of $4.58 billion. •...
Via
Benzinga
UK Trial On Mix-Match COVID-19 Vaccines Expanded To Add Moderna, Novavax Shots
April 14, 2021
Researchers said that a U.K. study of using different Covid-19 vaccines in two-dose inoculations is now expanded to include vaccines made by Moderna Inc (NASDAQ: ...
Via
Benzinga
Exposures
COVID-19
South African Variant Able To Elude Pfizer/BioNTech' Vaccine Protection, Israeli Study Shows: Report
April 12, 2021
According to a real-world data study in Israel, the coronavirus variant discovered in South Africa may dodge the protection provided by Pfizer Inc (NYSE: PFE) /...
Via
Benzinga
Exposures
COVID-19
CureVac to Report Fourth Quarter and Full-Year 2020 Financial Results and Business Updates on April 15, 2021
April 09, 2021
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / April 9, 2021 / CureVac N.V. (Nasdaq:CVAC), a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic...
From
CureVac
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Government, Officials Defend AstraZeneca's COVID-19 Shot: CNBC
April 08, 2021
The British government and health experts in the country have come forward to defend the COVID-19 vaccine developed by AstraZeneca plc’s (NASDAQ: AZN) and...
Via
Benzinga
Exposures
COVID-19
Europe's Drug Watchdog Concludes Possible Link Between AstraZeneca COVID-19 Vaccine And Blood Clots
April 07, 2021
The European Medicines Agency (EMA), after an in-depth analysis, has concluded that unusual blood clots should be listed as a “very rare side effect” of the...
Via
Benzinga
Exposures
COVID-19
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.